Brief: Mankind Pharma Says NCLT Approves Amalgamation Of BSV Pharma With Bharat Serums And Vaccines
28/03/2025 14:31
March 28 (Reuters) - Mankind Pharma Ltd MNKI.NS: MANKIND PHARMA LTD - NCLT APPROVES AMALGAMATION OF BSV PHARMA WITH BHARAT SERUMS AND VACCINES Source text: ID:nBSE1dlv3M Further company coverage: MNKI.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mankind Pharma
See all newsIndia's Mankind Pharma heads for best day in over 3 years as Q2 hints at recovery
Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
India's Mankind Pharma gains on higher quarterly profit
Brief: Mankind Pharma Says To Buy 70% Majority Stake In Armed Cell Therapeutics Through Unit
Kotak upgrades India's Mankind Pharma to 'buy' on signs of business recovery